CXCR2 and neoplasm: Given the role that CXCR2 plays in recruiting MDSCs to the tumor microenvironment, CXCR2 inhibition is a promising strategy to relieve MDSC-mediated immunosuppression and improve the effectiveness of existing immunotherapies.